Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $454.91 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IMPEL PHARMACEUTICALS INC. | $167.03 | 4 | $0 (2023) |
| PFIZER INC. | $121.07 | 3 | $0 (2024) |
| Lundbeck LLC | $72.63 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $34.51 | 2 | $0 (2024) |
| Novo Nordisk Inc | $28.10 | 2 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $16.78 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $14.79 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.54 | 6 | GlaxoSmithKline, LLC. ($34.51) |
| 2023 | $147.52 | 4 | PFIZER INC. ($88.61) |
| 2022 | $136.22 | 3 | IMPEL PHARMACEUTICALS INC. ($122.29) |
| 2021 | $72.63 | 1 | Lundbeck LLC ($72.63) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: VACCINES | ||||||
| 07/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiology | ||||||
| 05/23/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: VACCINES | ||||||
| 04/29/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Respiratory | ||||||
| 07/15/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $22.98 | General |
| Category: Neurology | ||||||
| 07/15/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| Category: Neurology | ||||||
| 07/14/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $88.61 | General |
| Category: PAIN | ||||||
| 03/21/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Obesity | ||||||
| 08/16/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Obesity | ||||||
| 07/17/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | In-kind items and services | $75.25 | General |
| Category: Migraine | ||||||
| 07/13/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | In-kind items and services | $47.04 | General |
| Category: Migraine | ||||||
| 07/16/2021 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $72.63 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 232 | 311 | $58,024 | $18,410 |
| 2022 | 4 | 115 | 179 | $39,888 | $7,997 |
| 2021 | 3 | 80 | 142 | $40,450 | $9,697 |
| 2020 | 3 | 69 | 114 | $26,983 | $6,749 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 48 | 48 | $13,536 | $5,694 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 99 | $21,483 | $5,219 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 50 | $16,000 | $3,984 | 24.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $1,620 | $1,291 | 79.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 19 | $3,724 | $1,071 | 28.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $946.00 | $687.50 | 72.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 42 | 55 | $715.00 | $462.00 | 64.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 98 | $20,580 | $4,305 | 20.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 36 | 36 | $9,828 | $2,302 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 30 | $9,300 | $1,345 | 14.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 15 | $180.00 | $44.10 | 24.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 96 | $23,520 | $4,508 | 19.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 30 | 30 | $11,250 | $4,088 | 36.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 16 | $5,680 | $1,101 | 19.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 28 | 28 | $8,601 | $3,371 | 39.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 68 | $13,324 | $2,302 | 17.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 18 | $5,058 | $1,076 | 21.3% |
About Martha Pollock
Martha Pollock is a Internal Medicine healthcare provider based in Berkley, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801856430.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Martha Pollock has received a total of $454.91 in payments from pharmaceutical and medical device companies, with $98.54 received in 2024. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($454.91).
As a Medicare-enrolled provider, Pollock has provided services to 496 Medicare beneficiaries, totaling 746 services with total Medicare billing of $42,853. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Berkley, MI
- Active Since 03/27/2006
- Last Updated 12/02/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801856430
Products in Payments
- Trudhesa (Drug) $167.03
- NURTEC ODT (Drug) $88.61
- VYEPTI (Biological) $72.63
- SHINGRIX (Biological) $34.51
- PAXLOVID (Drug) $32.46
- OPSUMIT (Drug) $16.78
- AIRSUPRA (Drug) $14.79
- Wegovy (Drug) $14.17
- Saxenda (Drug) $13.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Berkley
Dr. Armen Korkigian, Do, DO
Internal Medicine — Payments: $52,451
Dr. Hazim Al-Ameri, M.d, M.D
Internal Medicine — Payments: $40,037
Dr. Rita Shah, Md, MD
Internal Medicine — Payments: $13,176
Dr. William Rudy, D.o, D.O
Internal Medicine — Payments: $10,173
Neelum Gupta, M.d, M.D
Internal Medicine — Payments: $9,868
Abhishek Swami
Internal Medicine — Payments: $3,380